InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the full record of transactions filed by Paterson Dan, Co-Président. Director active across 1 companies, notably Verastem, Inc.. In total, 9 disclosures have been published. Total volume traded: €135k. The latest transaction was disclosed on 21 June 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
€2,9232,701 shares@ €1.08240.0005% mcap0.8% of flow
Common Stock
SEC:0001104659-22-073486:0·
015,000 shares0
Common Stock
SEC:0001104659-22-061939:0·
€3,2412,818 shares@ €1.150.0005% mcap0.9% of flow
Common Stock
SEC:0001104659-22-037009:0·
€42,41923,534 shares@ €1.80240.0071% mcap11.1% of flow
Common Stock
SEC:0001104659-22-001447:0·
€42,41923,534 shares@ €1.80240.0071% mcap22.6% of flow
Common Stock
SEC:0001104659-22-001447·
€22,19610,994 shares@ €2.01890.0037% mcap11.8% of flow
Common Stock
SEC:0001104659-21-152597·
€22,19610,994 shares@ €2.01890.0037% mcap5.8% of flow
Common Stock
SEC:0001104659-21-152597:0·
€122,86750,244 shares@ €2.44540.020% mcap65.5% of flow
Common Stock
SEC:0001104659-21-151116·
€122,86750,244 shares@ €2.44540.020% mcap32.2% of flow
Common Stock
SEC:0001104659-21-151116:0·
9 of 9 declarations
About Paterson Dan
Dan Paterson is the President and COO of Verastem, Inc., a biopharmaceutical company. He is responsible for the strategic direction and operations of the company. His expertise in the biopharmaceutical sector allows him to lead initiatives aimed at developing new treatments and improving patient outcomes.
